HKSE - Delayed Quote HKD

Natural Beauty Bio-Technology Limited (0157.HK)

0.500 0.000 (0.00%)
At close: April 26 at 3:52 PM GMT+8
Key Events
Loading Chart for 0157.HK
DELL
  • Previous Close 0.500
  • Open 0.490
  • Bid 0.500 x --
  • Ask 0.560 x --
  • Day's Range 0.490 - 0.500
  • 52 Week Range 0.440 - 0.600
  • Volume 90,000
  • Avg. Volume 28,000
  • Market Cap (intraday) 1.001B
  • Beta (5Y Monthly) -0.22
  • PE Ratio (TTM) --
  • EPS (TTM) -0.010
  • Earnings Date Feb 22, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 1, 2022
  • 1y Target Est --

Natural Beauty Bio-Technology Limited, an investment holding company, offers skin care products and services in Mainland China, Taiwan, and internationally. The company manufactures and sells aroma-therapeutic, cosmetics, health supplements, and make-up products under the Natural Beauty brand. It also offers skin treatment and consulting, medical cosmetology, and beauty consulting and training services. In addition, the company's spas provide hydrotherapy, facial treatment, body care, and skin care analysis services; skin care consulting; and beauty apparatus. Further, it engages in the wholesale of skin care and beauty products. Natural Beauty Bio-Technology Limited was founded in 1976 and is based in Kowloon, Hong Kong.

www.ir-cloud.com/hongkong/00157/irwebsite/

479

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 0157.HK

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

0157.HK
4.17%
HANG SENG INDEX
3.54%

1-Year Return

0157.HK
7.41%
HANG SENG INDEX
10.03%

3-Year Return

0157.HK
29.82%
HANG SENG INDEX
39.30%

5-Year Return

0157.HK
21.05%
HANG SENG INDEX
40.27%

Compare To: 0157.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0157.HK

Valuation Measures

Annual
As of 4/27/2024
  • Market Cap

    1.00B

  • Enterprise Value

    1.02B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.98

  • Price/Book (mrq)

    1.74

  • Enterprise Value/Revenue

    3.04

  • Enterprise Value/EBITDA

    44.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.50%

  • Return on Assets (ttm)

    0.03%

  • Return on Equity (ttm)

    -2.58%

  • Revenue (ttm)

    336.02M

  • Net Income Avi to Common (ttm)

    -15.11M

  • Diluted EPS (ttm)

    -0.010

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    168.93M

  • Total Debt/Equity (mrq)

    32.42%

  • Levered Free Cash Flow (ttm)

    -46.81M

Company Insights: 0157.HK

People Also Watch